| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EVP AND CFO | Common shares without par value | 50,616 | $6,714,718 | $132.66 | 01 Sep 2025 | Direct |
| ABBOTT LABORATORIES | EVP AND CFO | Common shares without par value | 363 | $46,972 | $129.40 | 01 Sep 2025 | Profit Sharing Trust |
| ABBOTT LABORATORIES | EVP AND CFO | Option (right to buy) | 83,783 | 25 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 01 Sep 2025 | 1 | -$51,339 | 4 | EVP AND CFO | 03 Sep 2025, 17:31 |
| ABT | ABBOTT LABORATORIES | 08 Aug 2025 | 1 | -$746,758 | 4 | EVP AND CFO | 11 Aug 2025, 17:53 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2025 | 1 | -$666,850 | 4 | EVP AND CFO | 04 Mar 2025, 19:21 |
| ABT | ABBOTT LABORATORIES | 25 Feb 2025 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 27 Feb 2025, 17:46 |
| ABT | ABBOTT LABORATORIES | 01 Sep 2024 | 1 | -$43,835 | 4 | EXECUTIVE VICE PRESIDENT | 04 Sep 2024, 20:03 |
| ABT | ABBOTT LABORATORIES | 29 Feb 2024 | 1 | -$208,647 | 4 | SENIOR VICE PRESIDENT | 04 Mar 2024, 18:44 |
| ABT | ABBOTT LABORATORIES | 21 Feb 2024 | 2 | $0 | 4 | SENIOR VICE PRESIDENT | 23 Feb 2024, 17:23 |
| ABT | ABBOTT LABORATORIES | 01 Sep 2023 | 2 | $0 | 4 | SENIOR VICE PRESIDENT | 06 Sep 2023, 18:53 |
| ABT | ABBOTT LABORATORIES | 16 Jun 2023 | 1 | -$848,000 | 4 | VICE PRESIDENT | 20 Jun 2023, 18:55 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 1 | -$147,360 | 4 | VICE PRESIDENT | 02 Mar 2023, 18:19 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | VICE PRESIDENT | 22 Feb 2023, 17:38 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 1 | -$145,913 | 4 | VICE PRESIDENT | 02 Mar 2022, 18:31 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 3 | -$112,819 | 4 | VICE PRESIDENT | 23 Feb 2022, 19:00 |
| ABT | ABBOTT LABORATORIES | 25 Oct 2021 | 1 | -$1,011,920 | 4 | VICE PRESIDENT | 27 Oct 2021, 18:22 |